- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Undifferentiated Ovarian Carcinoma
Total 26064 results
-
Jules Bordet InstituteCompletedOvarian Cancer | Peritoneal CarcinomatosisBelgium
-
Floor BackesEisai Inc.CompletedFallopian Tube Carcinoma | Recurrent Endometrial Cancer | Primary Peritoneal Carcinoma | Recurrent Ovarian CancerUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Ovarian Carcinoma | Primary Peritoneal Carcinoma | Stage IV Fallopian Tube Cancer | Stage IV Ovarian Cancer | Stage III Ovarian Cancer | Stage III Fallopian Tube Cancer | Stage II Ovary Cancer | Stage II Ovarian Cancer | Stage III Ovary Cancer and other conditionsUnited States
-
National Cancer Institute (NCI)NRG OncologyWithdrawnRecurrent Ovarian High Grade Serous Adenocarcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Recurrent Fallopian Tube Endometrioid Adenocarcinoma | Recurrent Ovarian Endometrioid Adenocarcinoma | Recurrent Platinum-Resistant Fallopian Tube Carcinoma | Recurrent Platinum-Resistant Primary... and other conditionsUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Withdrawn
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingRenal Cell Carcinoma | Cervical Cancer | Endometrial Cancer | Urothelial Carcinoma | Ovarian Cancer RecurrentChina
-
Sumitomo Pharma America, Inc.TerminatedFallopian Tube Cancer | Primary Peritoneal Cancer | Urothelial Carcinoma | Renal Cell Carcinoma (RCC) | Platinum-resistant Ovarian Cancer (PROC) | Serous Epithelial Ovarian CancerUnited States, Canada
-
Lei LiUnknownOvarian Cancer | High Grade Serous Carcinoma | Prognosis | Early Diagnosis | ExosomesChina
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)WithdrawnRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Malignant Ovarian Clear Cell Tumor | Stage IIIA Fallopian Tube Cancer | Stage IIIA Ovarian Cancer | Stage IIIA Primary Peritoneal Cancer | Stage IIIB Fallopian Tube Cancer | Stage IIIB Ovarian... and other conditions
-
The Affiliated Hospital of the Chinese Academy...Recruiting
-
Fondazione Policlinico Universitario Agostino Gemelli...Recruiting
-
Shandong UniversityRecruitingObjective Response RateChina
-
Uppsala University HospitalUppsala University; The Netherlands Cancer InstituteRecruitingOvarian Cancer RecurrentSweden
-
Zai Lab (Shanghai) Co., Ltd.Active, not recruitingPlatinum-sensitive Relapsed Ovarian CancerChina
-
Medical University of ViennaCompletedOvarian Epithelial CancerAustria, Belgium, Czechia, Germany
-
National Cancer Centre, SingaporeCompleted
-
University Hospital, BrestCompleted
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityUnknownPredictive Cancer ModelChina
-
Ayana Pharma Ltd.,Lambda Therapeutic Research Ltd.CompletedOvarian Cancer RecurrentIndia
-
Centre Francois BaclesseLigue contre le cancer, France; Fondation de FranceCompleted
-
ARCAGY/ GINECO GROUPCompletedOvarian Cancer RecurrentFrance
-
Priv.-Doz. Dr. med. Joachim RomCompletedEpithelial Ovarian CancerGermany
-
National Cancer Institute (NCI)CompletedOvarian CancerUnited States
-
Leiden University Medical CenterUniversity Medical Center GroningenCompletedRecurrent Ovarian CancerNetherlands
-
Wuhan UniversityUnknown
-
Northwestern UniversityNational Cancer Institute (NCI)TerminatedOvarian CancerUnited States
-
GERCOR - Multidisciplinary Oncology Cooperative...Unknown
-
NRG OncologyNational Cancer Institute (NCI)RecruitingOvarian CarcinomaUnited States, Korea, Republic of
-
Zhongda HospitalNot yet recruitingOvarian Cancer, EpithelialChina
-
Peking Union Medical College HospitalZai Lab (Shanghai) Co., Ltd.Not yet recruiting
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingPlatinum-resistant Recurrent Ovarian CancerChina
-
West China Second University HospitalNot yet recruitingRecurrent Ovarian CancerChina
-
Hospital Clinic of BarcelonaRecruitingAdvanced Ovarian CancerSpain
-
Xinhua Hospital, Shanghai Jiao Tong University...WithdrawnPlatinum-resistant Ovarian CancerChina
-
AstraZenecaEuropean Network of Gynaecological Oncological Trial Groups (ENGOT)CompletedEpithelial Ovarian CancerDenmark, France, Germany, Italy, Spain, Poland, Belgium, Canada, United Kingdom, Israel, Norway
-
AstraZenecaCompletedRelapsed Ovarian Cancer, BRCA Mutation, Platinum SensitivityUnited States, Canada
-
The Affiliated Hospital of Qingdao UniversityCompletedHigh-Grade Serous Ovarian CancerChina
-
PsiOxus Therapeutics LtdCompletedRecurrent Platinum Resistant Ovarian CancerUnited Kingdom, Spain
-
Jihong LiuUnknownPlatinum-resistant Ovarian CancerChina
-
Fondazione Policlinico Universitario Agostino Gemelli...UnknownEpithelial Ovarian Cancer
-
Medical University of ViennaCompletedOvarian Epithelial CancerAustria, Germany, Belgium, Czechia
-
University of Maryland, BaltimoreUniversity of Maryland Greenebaum Cancer CenterCompleted
-
Centre Francois BaclesseARCAGY/ GINECO GROUP; French Cancer Research Hospital ProgramCompletedPlatinum-resistant or Refractory Ovarian CancerFrance
-
AGC Biologics S.p.A.CompletedOvarian Cancer Metastatic RecurrentItaly
-
Yonsei UniversityCompletedOvarian Cancer (Epithelial)Korea, Republic of
-
PharmaMar, SpainCompleted
-
AccentureCompletedRecurrent Platinum-resistant Ovarian CancerAustralia, Russian Federation, United Kingdom
-
Chong Kun Dang PharmaceuticalCompletedEpithelial Ovarian CancerKorea, Republic of
-
AstraZenecaMyriad Genetic Laboratories, Inc.WithdrawnPlatinum Sensitive Relapsed Ovarian CancerUnited States, Korea, Republic of, Peru, United Kingdom, Philippines